Heidelberg Engineering has partnered with sight-saving charity Orbis to fund research and training for eyecare professionals around the world via Cybersight, Orbis’s telemedicine and e-learning platform.
Cybersight webinars reached over 15,000 attendees in the first half of 2023, and Heidelberg’s funding will now help deliver even more webinars on topics including optical coherence tomography, said Heidelberg and Orbis in a joint statement. “The new sessions have the potential to equip thousands of ophthalmic professionals worldwide to provide higher quality eyecare for their communities.”
Heidelberg’s funding will also allow Orbis to continue its research project into retinoblastoma, which affects 9,000 children worldwide each year, with 92% of children diagnosed living in low- and middle-income countries where late diagnosis, limited accessibility to eyecare and lack of treatment-specific resources contribute to a 40% survival rate within three years of diagnosis. “The project will investigate the impact of artificial intelligence on worldwide retinoblastoma care. It will also look at how treatment, outcomes and disease-specific knowledge continues to change over time,” they said.
